Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. (ENDV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENDV · as of Jun 9, 2026
Key Statistics
Explore Endonovo Therapeutics, Inc. Data
endv stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
endv competitorsENDV
AFFY
AMBS
BSSP
CNBX
GNLKQStock Performance
Full HistoryAbout Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine…
what is endonovo therapeutics, inc. · endv stock overview · endonovo therapeutics, inc. company profile · who is endonovo therapeutics, inc. ceo · endv OTC · endonovo therapeutics, inc. headquarters · endonovo therapeutics, inc. business segments
About Stock Overview & Key Data
Endonovo Therapeutics, Inc. (ENDV) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 15, 2012. As of the latest trading session, ENDV stock price is $0.00, with a market capitalization of $31,875. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, Endonovo Therapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Endonovo Therapeutics, Inc. (ENDV) stock price is $0.00. The stock is traded on OTC under the ticker symbol ENDV. The 52-week range is $0.00 – $0.00.